Compounds > isoxazoles
Page last updated: 2024-08-21

isoxazoles and ER-Negative PR-Negative HER2-Negative Breast Cancer

isoxazoles has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (50.00)24.3611
2020's4 (50.00)2.80

Authors

AuthorsStudies
Kim, ES; Kim, S; Moon, A1
Ishii, T; Itou, J; Sato, F; Tanaka, S; Toi, M1
Deng, Y; Ding, TB; Dong, JB; He, SH; Hu, JC; Jiang, XC; Lou, B; Mo, MG; Yang, JT; Ye, DY; Yu, K; Zhou, L1
Ahirwar, DK; Charan, M; Chatterjee, N; Das, S; Ganju, RK; Kaul, K; Mishra, S; Misri, S; Satoskar, AR; Varikuti, S1
Boughey, JC; Goetz, MP; Harmsen, WS; Kahila, MM; Kalari, KR; Lou, Z; Mutter, RW; Sarkaria, JN; Tu, X; Wang, L; Yu, J; Yuan, J; Zhou, Q1
Chrysikos, D; Dimopoulos, MA; Papadimitriou, CA; Psaltopoulou, T; Sergentanis, TN; Zagouri, F1
Berghuis, P; de Vries, EG; Gaykema, SB; Kosterink, JG; Lub-de Hooge, MN; Nienhuis, HH; Pot, L; Schröder, CP; Terwisscha van Scheltinga, AG; Timmer-Bosscha, H1
Asara, JM; Brown, KK; Spinelli, JB; Toker, A1

Reviews

1 review(s) available for isoxazoles and ER-Negative PR-Negative HER2-Negative Breast Cancer

ArticleYear
Hsp90 inhibitors in breast cancer: a systematic review.
    Breast (Edinburgh, Scotland), 2013, Volume: 22, Issue:5

    Topics: Adenine; Antineoplastic Agents; Benzamides; Benzoquinones; Biomarkers, Tumor; Female; Glycine; HSP70 Heat-Shock Proteins; HSP90 Heat-Shock Proteins; Humans; Indazoles; Isoxazoles; Lactams, Macrocyclic; Pyridines; Resorcinols; Triazoles; Triple Negative Breast Neoplasms

2013

Other Studies

7 other study(ies) available for isoxazoles and ER-Negative PR-Negative HER2-Negative Breast Cancer

ArticleYear
A novel isoxazole compound CM2-II-173 inhibits the invasive phenotype of triple-negative breast cancer cells.
    Oncology research, 2023, Volume: 31, Issue:6

    Topics: Apoptosis; Female; Fingolimod Hydrochloride; Humans; Isoxazoles; Male; Ovarian Neoplasms; Triple Negative Breast Neoplasms

2023
Eribulin mesylate-induced c-Fos upregulation enhances cell survival in breast cancer cell lines.
    Biochemical and biophysical research communications, 2020, 05-21, Volume: 526, Issue:1

    Topics: Animals; Antineoplastic Agents; Apoptosis; Benzophenones; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colchicine; Female; Furans; Gene Expression Regulation, Neoplastic; Humans; Isoxazoles; Ketones; Mice, Inbred BALB C; Mice, Nude; Microtubules; Paclitaxel; Proto-Oncogene Proteins c-fos; RNA, Messenger; Triple Negative Breast Neoplasms; Up-Regulation

2020
Sphingomyelin synthase 2 facilitates M2-like macrophage polarization and tumor progression in a mouse model of triple-negative breast cancer.
    Acta pharmacologica Sinica, 2021, Volume: 42, Issue:1

    Topics: Animals; Antineoplastic Agents; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Disease Progression; Enzyme Inhibitors; Female; Gene Knockout Techniques; Humans; Immunity, Cellular; Isoxazoles; Macrophage Activation; Macrophages; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Prognosis; Transferases (Other Substituted Phosphate Groups); Triple Negative Breast Neoplasms

2021
Macrophage migration inhibitory factor inhibition as a novel therapeutic approach against triple-negative breast cancer.
    Cell death & disease, 2020, 09-17, Volume: 11, Issue:9

    Topics: Animals; Apoptosis; Caspases; Cell Movement; Cell Survival; Cytochromes c; Disease Progression; Enzyme Activation; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; In Vitro Techniques; Inflammation; Intramolecular Oxidoreductases; Isoxazoles; Macrophage Migration-Inhibitory Factors; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; Mice, Knockout; Mice, SCID; Morpholines; Neoplasm Metastasis; Neoplasm Transplantation; Treatment Outcome; Triple Negative Breast Neoplasms; Wound Healing

2020
ATR Inhibition Is a Promising Radiosensitizing Strategy for Triple-Negative Breast Cancer.
    Molecular cancer therapeutics, 2018, Volume: 17, Issue:11

    Topics: Animals; Ataxia Telangiectasia Mutated Proteins; cdc25 Phosphatases; Cell Cycle Checkpoints; Cell Line, Tumor; Checkpoint Kinase 1; DNA Breaks, Double-Stranded; Drug Resistance, Neoplasm; Female; Homologous Recombination; Humans; Isoxazoles; Mice, Inbred NOD; Mice, SCID; Phosphorylation; Proteolysis; Pyrazines; Radiation-Sensitizing Agents; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays

2018
Visualising dual downregulation of insulin-like growth factor receptor-1 and vascular endothelial growth factor-A by heat shock protein 90 inhibition effect in triple negative breast cancer.
    European journal of cancer (Oxford, England : 1990), 2014, Volume: 50, Issue:14

    Topics: Animals; Down-Regulation; Female; HSP90 Heat-Shock Proteins; Humans; Isoxazoles; Male; MCF-7 Cells; Mice; Mice, Inbred BALB C; Receptor, IGF Type 1; Resorcinols; Triple Negative Breast Neoplasms; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays

2014
Adaptive Reprogramming of
    Cancer discovery, 2017, Volume: 7, Issue:4

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cellular Reprogramming; DNA Damage; Doxorubicin; Drug Resistance, Neoplasm; Female; Humans; Isoxazoles; Leflunomide; Mice; Pyrimidines; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays

2017